cryptotanshinone has been researched along with Cardiotoxicity in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Dong, J; Fan, X; Han, Y; Li, J; Li, L; Li, P; Wu, B; Zhao, Q | 1 |
Cao, J; Jiang, Q; Jiang, Y; Li, C; Lu, L; Sun, Q; Wang, Q; Wang, X; Wang, Y; Wei, P; Zhang, Y | 1 |
Chen, L; Li, F; Shu, J; Wang, H; Yao, Y; Ying, MZ; Zhang, Y | 1 |
3 other study(ies) available for cryptotanshinone and Cardiotoxicity
Article | Year |
---|---|
Attenuation of doxorubicin-induced cardiotoxicity by
Topics: Animals; Apoptosis; Cardiotonic Agents; Cardiotoxicity; Computational Biology; Databases, Genetic; Disease Models, Animal; Doxorubicin; Gene Expression Profiling; Heart; Heart Diseases; Metabolic Networks and Pathways; Myocytes, Cardiac; Phenanthrenes; Rats; Reactive Oxygen Species; Signal Transduction; Transcriptome | 2020 |
Cryptotanshinone Ameliorates Doxorubicin-Induced Cardiotoxicity by Targeting Akt-GSK-3β-mPTP Pathway In Vitro.
Topics: Animals; Apoptosis; Cardiotoxicity; Cell Line, Tumor; Doxorubicin; Glycogen Synthase Kinase 3 beta; Membrane Potential, Mitochondrial; Mitochondrial Membrane Transport Proteins; Mitochondrial Membranes; Mitochondrial Permeability Transition Pore; Myocytes, Cardiac; Oxidative Stress; Phenanthrenes; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Reactive Oxygen Species; Signal Transduction | 2021 |
Cryptotanshinone protects against adriamycin-induced mitochondrial dysfunction in cardiomyocytes.
Topics: Adenosine Triphosphate; Animals; Cardiomyopathies; Cardiotoxicity; Disease Models, Animal; Doxorubicin; Drugs, Chinese Herbal; Male; Membrane Potential, Mitochondrial; Mitochondria, Heart; Myocytes, Cardiac; Oxidative Stress; Phenanthrenes; Rats, Wistar; Salvia miltiorrhiza | 2016 |